M

MeiraGTx Holdings plc
D

MGTX

6.17000
USD
0.33
(5.65%)
Market Closed
Volume
0
EPS
-2
Div Yield
-
P/E
-5
Market Cap
482,206,484
OverviewSignalsIdeasNews
Related Instruments
    M
    MGIC
    0.110
    (0.92%)
    12.060 USD
    M
    MGNI
    0.617
    (3.93%)
    16.327 USD
    S
    SABR
    0.05500
    (1.45%)
    3.85500 USD
    T
    TTWO
    0.530
    (0.29%)
    181.900 USD
    More
News

Title: MeiraGTx Holdings plc

Sector: Healthcare
Industry: Biotechnology
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.